Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients

BACKGROUND: Coagulopathies are a major class among COVID-19 associated complications. Although anticoagulants such as unfractionated Heparin and Enoxaparin are both being used for therapeutic mitigation of COVID associated coagulopathy (CAC), differences in their clinical outcomes remain to be inves...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EClinicalMedicine
Main Authors: Pawlowski, Colin, Venkatakrishnan, AJ, Kirkup, Christian, Berner, Gabriela, Puranik, Arjun, O'Horo, John C., Badley, Andrew D., Soundararajan, Venky
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941023/
https://ncbi.nlm.nih.gov/pubmed/33718845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2021.100774
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados